- Report
- April 2024
- 573 Pages
Global
From €5414EUR$5,600USD£4,650GBP
- Report
- February 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- January 2024
- 150 Pages
Global
From €4689EUR$4,850USD£4,028GBP
- Report
- June 2023
- 118 Pages
Global
From €4737EUR$4,900USD£4,069GBP
- Report
- July 2022
- 100 Pages
Global
From €2659EUR$2,750USD£2,284GBP
- Report
- November 2021
- 545 Pages
Global
From €3867EUR$4,000USD£3,322GBP
- Report
- February 2023
- 427 Pages
Global
From €5540EUR$5,730USD£4,758GBP
- Book
- April 2016
- 4696 Pages
- Book
- November 2012
- 456 Pages
The Chromosomal Disease market is a subset of the Healthcare Services industry, focusing on the diagnosis, treatment, and management of genetic disorders caused by chromosomal abnormalities. These diseases can be caused by a variety of factors, including genetic mutations, environmental exposures, and lifestyle choices. Treatment options vary depending on the type and severity of the disorder, and may include medications, physical therapy, and lifestyle modifications.
Chromosomal Disease services are provided by a variety of healthcare providers, including hospitals, clinics, and specialty centers. These providers offer a range of services, including genetic counseling, diagnostic testing, and treatment options. Additionally, many organizations provide support services for patients and families affected by these disorders.
Companies in the Chromosomal Disease market include Illumina, Inc., Invitae Corporation, Myriad Genetics, Inc., and Counsyl, Inc. Show Less Read more